Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Masahiro Takahashi"'
Autor:
Yoshikazu Takahashi, Hidekazu Shirota, Takashi Yoshioka, Takuhiro Yamaguchi, Kota Ouchi, Michio Kuroki, Shin Takahashi, Masahiro Takahashi, Masaki Tanaka, Masanobu Takahashi, Chikashi Ishioka, Yasuhiro Sakamoto, Hideki Shimodaira, Hiroo Imai, Satoshi Kato, Keigo Komine, Kazunori Otsuka, Hiroyuki Shibata, Hisatsugu Ohori, Hiroaki Yamaguchi, Yasushi Tsuji
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose The current study aimed to determine the efficacy of trifluridine/tipiracil for elderly patients with advanced colorectal cancer. Methods This single-arm, open-label, multicenter, phase II study included elderly patients aged 65 years or more
Autor:
Shingo Hatakeyama, Senji Hoshi, Shigeto Ishidoya, Sadafumi Kawamura, Norihiko Tsuchiya, Masahiro Takahashi, Tomonori Habuchi, Shintaro Narita, Chikara Ohyama, Jiro Shimoda, Koji Mitsuzuka, Akihiro Ito, Takuma Narita, Yoichi Arai, Toshihiko Sakurai, Toshiaki Kawaguchi
Publikováno v:
Transl Androl Urol
Background The clinical benefit of the combined androgen blockade (CAB) therapy over luteinizing hormone-releasing hormone analog (LH-RHa) monotherapy for hormone naive metastatic prostate cancer (mHNPC) is unclear. Therefore, we retrospectively comp
Autor:
Shigeto Ishidoya, Masanori Ishida, Shintaro Narita, Chikara Ohyama, Kazutaka Okita, Akihiro Ito, Jiro Shimoda, Toshiaki Kawaguchi, Koji Mitsuzuka, Shingo Hatakeyama, Senji Hoshi, Hiromi Sato, Sadafumi Kawamura, Norihiko Tsuchiya, Tomonori Habuchi, Masahiro Takahashi, Toshihiko Sakurai, Yoichi Arai
Publikováno v:
Clinical Genitourinary Cancer. 18:e103-e111
Introduction We aimed to evaluate the treatment sequence for patients with metastatic castration-resistant prostate cancer (mCRPC) in real-world practice and compare overall survival in each sequential therapy. Patients and Methods We retrospectively
Autor:
Kota Ouchi, Masanobu Takahashi, Chikashi Ishioka, Hidekazu Shirota, Hiroo Imai, Yuko Sato, Keigo Komine, Shin Takahashi, Masahiro Takahashi, Sakura Hiraide, Ken Saijo
Publikováno v:
International Journal of Clinical Oncology
Background Pseudomyxoma peritonei (PMP) is a rare malignancy, and there is insufficient evidence about systemic chemotherapy for this disease. Methods We retrospectively evaluated the efficacy and safety of a chemotherapeutic regimen with 5-fluoroura
Autor:
Kota Ouchi, Yuya Yoshida, Hidekazu Shirota, Masahiro Takahashi, Ken Saijo, Keiju Sasaki, Masanobu Takahashi, Asako Suzuki, Keigo Komine, Shin Takahashi, Hiroo Imai, Chikashi Ishioka
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2020 (2020)
Journal of Oncology, Vol 2020 (2020)
Background. Oxaliplatin and irinotecan are generally used to treat advanced colorectal cancer (CRC) patients. Antibiotics improve the cytotoxicity of oxaliplatin but not irinotecan in a colon cancer cell line in vitro. This study retrospectively asse
Autor:
Kota Ouchi, Chikashi Ishioka, Yoshinari Okada, Ken Saijo, Masanobu Takahashi, Yoshifumi Kawamura, Sho Umegaki, Keigo Komine, Hidekazu Takahashi, Hisatsugu Ohori, Hiroo Imai, Makio Gamoh, Yuko Sato, Hidekazu Shirota, Masahiro Takahashi, Sakura Hiraide, Akira Okita, Shin Takahashi
Publikováno v:
The Tohoku Journal of Experimental Medicine. 245:123-129
The combinations of oral fluoropyrimidines and cisplatin such as capecitabine and cisplatin (XP) or S-1 and cisplatin (SP) are regarded as a standard therapy against unresectable, recurrent, or advanced gastric cancer (AGC). Especially, SP is the mos
Autor:
Keiji Okada, Hiroyuki Manabe, Masahiro Takahashi, Wataru Yamazaki, Naoaki Misawa, Takumi Yamamoto
Publikováno v:
The Journal of Veterinary Medical Science
Digital Dermatitis is a localized infectious dermatitis caused by Treponema-like spirochetes. Antibiotics, such as lincomycin, are currently used for treatment, but their use imposes a withdrawal period. This study investigated the therapeutic effect
Autor:
Yoshinari Okada, Ken Saijo, Keigo Komine, Hideki Shimodaira, Chikashi Ishioka, Hiroo Imai, Masahiro Takahashi, Kota Ohuchi, Hideharu Yamada, Masanobu Takahashi, Shin Takahashi
Publikováno v:
Journal of Bone Oncology, Vol 6, Iss C, Pp 37-40 (2017)
Background Bone is a metastatic site for various types of cancer. Cancer patients in whom bone metastases progress often have skeletal-related events (SREs). Denosumab and zoledronic acid are both bone-modifying agents that prevent the occurrence of
Autor:
Masahiro Takahashi, Shou Taniuchi, Satoshi Okabe, Mamoru Oshiki, Rathnayake M.L.D. Rathnayake, Yuji Miyazaki, Hisashi Satoh
Publikováno v:
Analytical Sciences. 33(7):825-830
An ionophore-doped sensing membrane phosphate (PO4) microsensor based on bis(dibromophenylstannyl)methane (Bis microsensor) is described. The Bis microsensor showed a Nernstian response. The response of the Bis microsensor was log-linear down to a mo
Autor:
Masaki Inoue, Kensuke Sasaki, Hideyuki Sakoda, Masahiro Takahashi, Yasuka Matsunaga, Akifumi Kushiyama, Yu Mizuno, Koji Ueda, Takao Masaki, Yusuke Nakatsu, Takako Kikuchi, Tomoichiro Asano, Hiraku Ono, Midori Fujishiro, Kenichi Morii, Takeshi Yamamotoya
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 19
International Journal of Molecular Sciences, Vol 20, Iss 19, p 4680 (2019)
Volume 20
Issue 19
International Journal of Molecular Sciences, Vol 20, Iss 19, p 4680 (2019)
Hyperuricemia has been recognized as a risk factor for insulin resistance as well as one of the factors leading to diabetic kidney disease (DKD). Since DKD is the most common cause of end-stage renal disease, we investigated whether febuxostat, a xan